Based on the latest industry insights and trends, here are the pharmaceutical services expected to be most in demand in 2025:
1. AI-Driven Drug Discovery and Development
The integration of artificial intelligence in R&D is set to accelerate drug development processes and reduce costs. Pharmaceutical companies are heavily investing in AI and machine learning tools to foster innovation and improve efficiency3. For instance, Amgen has doubled its clinical trial enrollment speed using AI-powered tools3.
2. Personalized Medicine Services
The shift towards treatments tailored to individual patients or genetic profiles is gaining momentum. By 2025, personalized medicine is expected to lead the next generation of healthcare, promising earlier diagnosis and improved patient outcomes4.
3. Digital Therapeutics Development
As the industry evolves, there's growing interest in digital therapeutics. These software-based interventions are becoming an integral part of treatment strategies, especially for chronic conditions4.
4. GLP-1 Related Research and Development
With the GLP-1 market projected to reach $200 billion, services related to researching and developing these drugs for various conditions beyond diabetes and obesity will be in high demand1.
5. Novel Modalities and Mechanisms of Action (MOAs)
There's a significant focus on developing new modalities and MOAs, with a 40% increase in first approvals for novel modalities in 2023. Services supporting the development of fusion proteins, oligonucleotide therapies, and multispecific antibodies will be crucial3.
6. Clinical Trial Optimization
Services that make clinical trials more inclusive, efficient, and patient-centric will be essential. This includes using AI to reduce patient recruitment timelines and improve trial design3.
7. Supply Chain Optimization and Resilience
With geopolitical uncertainties and the need for self-sufficiency, services that help optimize and build resilience in pharmaceutical supply chains will be in high demand. This includes implementing smart manufacturing and AI-driven supply chain management3.
8. Biologic Drug Manufacturing
The continuing biologics boom is driving demand for manufacturing services, particularly for subcutaneous injection formulations. However, there's also growing interest in alternative routes of administration for biologics6.
9. Digital and Connected Drug Delivery Solutions
As sensing technology and AI capabilities advance, there's renewed interest in digital and connected drug delivery systems. Services that can leverage these technologies to provide treatment-relevant insights will be valuable6.
10. Cancer Vaccine Development
With promising data emerging from companies like Moderna and BioNTech, services supporting cancer vaccine development and clinical trials are likely to be in high demand5.These services reflect the industry's focus on leveraging cutting-edge technologies, personalizing treatments, and improving efficiency across the drug development and delivery process. As the pharmaceutical industry continues to evolve, companies that can provide these services effectively will be well-positioned for success in 2025.
References:
- https://www2.deloitte.com/us/en/insights/industry/health-care/life-sciences-and-health-care-industry-outlooks/2025-life-sciences-executive-outlook.html
- https://www.cas.org/resources/cas-insights/scientific-breakthroughs-2025-emerging-trends-watch
- https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond
- https://themedicinemaker.com/business-regulation/trends-and-therapeutic-areas-to-watch-in-2025
- https://www.genengnews.com/insights/trends-for-2025/seven-biopharma-trends-to-watch-in-2025/
- https://www.drugdeliveryleader.com/doc/reasons-why-2025-is-the-year-pharma-companies-will-revisit-their-drug-delivery-device-strategies-0001
- https://www.wns.com/perspectives/articles/articledetail/220/top-4-pharmaceutical-industry-trends-in-2025
- https://www.fiercepharma.com/pharma/roche-projected-win-2025-drug-sales-novo-and-lilly-continue-climb-rankings-evaluate